A type of mutation that begins in bone marrow, not in the heart itself, is silently raising the risk of heart attacks and ...

Daniel Cressy’s illness was a barrier to getting his pilot’s license, until a novel treatment was approved in the United ...

Spread the love“`html The quest to reverse aging has long captivated scientists and laypeople alike. For decades, the dream ...

AHSCT resets the immune system in highly active RRMS after high-efficacy drugs fail, delivering higher NEDA, fewer relapses, and durable function gains. When high-efficacy drugs stop holding relapsing ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...

Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing toward true long-term cures.

A Nashville doctor helped pioneer an FDA approved "state-of-the-art" gene-editing therapy that could be a cure for painful ...

Thursday afternoon was filled with an abundance of smiles, and maybe a few tears at the University of Miami Multiple ...

Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived ...

Stanford University researchers have demonstrated that stem cell-derived vascular organoids can regenerate damaged ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...